avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr2c2
|
ENSMUSG00000005893.8 | nuclear receptor subfamily 2, group C, member 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nr2c2 | mm10_v2_chr6_+_92091378_92091390 | -0.66 | 1.1e-05 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.1 | 48.4 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
3.8 | 22.7 | GO:0008355 | olfactory learning(GO:0008355) |
3.1 | 12.5 | GO:0006069 | ethanol oxidation(GO:0006069) |
2.4 | 7.3 | GO:2001293 | fatty-acyl-CoA biosynthetic process(GO:0046949) malonyl-CoA metabolic process(GO:2001293) |
2.2 | 23.9 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
2.0 | 24.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
2.0 | 7.9 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
1.8 | 8.9 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.8 | 5.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.7 | 5.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.6 | 4.8 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
1.4 | 4.3 | GO:0042335 | cuticle development(GO:0042335) |
1.2 | 3.7 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
1.2 | 6.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.2 | 3.6 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
1.2 | 8.4 | GO:0006108 | malate metabolic process(GO:0006108) regulation of NADP metabolic process(GO:1902031) |
1.2 | 3.5 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.1 | 3.3 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
1.0 | 5.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.0 | 3.9 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
1.0 | 3.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.0 | 3.9 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
1.0 | 2.9 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.9 | 2.8 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.9 | 2.8 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.9 | 2.8 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.9 | 24.6 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.9 | 5.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.9 | 5.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.8 | 5.9 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.8 | 7.0 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.8 | 3.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.7 | 2.2 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.7 | 3.7 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.7 | 7.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.7 | 2.1 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.7 | 2.1 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.7 | 2.1 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.7 | 2.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.7 | 4.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.6 | 2.6 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.6 | 1.9 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
0.6 | 2.5 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.6 | 1.9 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.6 | 3.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.6 | 1.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.6 | 3.0 | GO:1901098 | negative regulation of autophagosome maturation(GO:1901097) positive regulation of autophagosome maturation(GO:1901098) |
0.6 | 4.1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.6 | 4.1 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.6 | 1.7 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.6 | 1.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.6 | 2.8 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.6 | 1.7 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.5 | 4.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.5 | 3.3 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.5 | 1.6 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.5 | 4.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 1.5 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.5 | 2.0 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.5 | 1.5 | GO:0090155 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of sphingolipid biosynthesis involved in cellular sphingolipid homeostasis(GO:0090157) |
0.5 | 2.4 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.5 | 1.4 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.5 | 2.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.5 | 3.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.5 | 1.8 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.5 | 3.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.5 | 6.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.4 | 6.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 | 1.7 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.4 | 2.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 1.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.4 | 1.2 | GO:0038190 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) |
0.4 | 1.2 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.4 | 1.2 | GO:0046032 | ADP catabolic process(GO:0046032) |
0.4 | 1.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.4 | 1.5 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.4 | 3.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.4 | 1.8 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.4 | 1.8 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.4 | 2.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.3 | 6.6 | GO:0072189 | ureter development(GO:0072189) |
0.3 | 2.4 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.3 | 3.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 1.7 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.3 | 1.4 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.3 | 1.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.3 | 3.3 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 4.4 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.3 | 0.6 | GO:0003130 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
0.3 | 1.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 2.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 1.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 2.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 1.2 | GO:0003360 | brainstem development(GO:0003360) |
0.3 | 0.6 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.3 | 2.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 12.2 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 2.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.3 | 3.7 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 0.6 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.3 | 2.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 1.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 3.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 0.8 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.3 | 1.3 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.3 | 2.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 0.8 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 1.8 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.3 | 1.3 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.3 | 0.8 | GO:0006114 | glycerol biosynthetic process(GO:0006114) positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
0.2 | 1.5 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.2 | 2.7 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 0.7 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
0.2 | 0.7 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.2 | 0.7 | GO:0006788 | heme oxidation(GO:0006788) |
0.2 | 7.9 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.2 | 1.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 4.0 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 2.2 | GO:0072641 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.2 | 2.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 0.9 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.2 | 2.6 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 1.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 13.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 0.8 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 1.2 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 1.8 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.2 | 7.3 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.2 | 2.9 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 3.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 2.3 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.2 | 1.7 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 2.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 2.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 0.5 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.2 | 1.1 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 2.6 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.2 | 2.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 1.5 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 0.5 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.2 | 1.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.5 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
0.2 | 0.9 | GO:0070627 | ferrous iron import(GO:0070627) |
0.2 | 2.3 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.6 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.6 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 1.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.7 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 1.6 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.7 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.6 | GO:1990839 | response to endothelin(GO:1990839) |
0.1 | 1.3 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 2.4 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 1.2 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 2.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 1.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 1.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 1.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 2.6 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.8 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 1.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 2.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.9 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 1.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.9 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.2 | GO:0072141 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.1 | 1.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.4 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.1 | 4.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.9 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 1.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.5 | GO:0032819 | regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) |
0.1 | 0.5 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 1.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 1.5 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 7.0 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 3.4 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 1.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.9 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 1.0 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.1 | 0.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 1.9 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.4 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.1 | 1.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 1.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 1.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 1.9 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.4 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 2.5 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 1.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 1.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 2.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 3.8 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 2.9 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.2 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.1 | 0.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 1.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 1.2 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.8 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 1.1 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 1.5 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.5 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 2.4 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.6 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.0 | 0.7 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.0 | 2.0 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 3.8 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.7 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.7 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 1.6 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 1.5 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 6.0 | GO:0009636 | response to toxic substance(GO:0009636) |
0.0 | 0.9 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 1.8 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.8 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.7 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) |
0.0 | 0.6 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.6 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 1.8 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 1.7 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.1 | GO:0051030 | snRNA transport(GO:0051030) |
0.0 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.4 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 1.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.5 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.9 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.2 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 1.3 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.0 | 5.1 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.0 | 0.2 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.0 | 0.4 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 1.0 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 3.6 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.8 | GO:0042755 | eating behavior(GO:0042755) |
0.0 | 1.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 1.5 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.0 | 0.6 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 2.2 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 3.2 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 0.3 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.8 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.4 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.0 | 0.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.1 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.0 | 0.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 3.8 | GO:0036019 | endolysosome(GO:0036019) |
0.9 | 2.7 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.7 | 8.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.7 | 8.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.6 | 2.4 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.6 | 0.6 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.6 | 3.9 | GO:0033503 | HULC complex(GO:0033503) |
0.5 | 48.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.5 | 3.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 3.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 1.6 | GO:0035339 | SPOTS complex(GO:0035339) |
0.4 | 1.9 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.4 | 1.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 2.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 1.0 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 8.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 2.7 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.3 | 14.2 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.3 | 1.2 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.3 | 2.6 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.3 | 2.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.3 | 0.8 | GO:0099631 | postsynaptic endocytic zone cytoplasmic component(GO:0099631) |
0.3 | 2.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 2.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 3.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 5.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 8.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 3.3 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 31.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.2 | 1.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 4.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 1.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 6.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 2.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.6 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.7 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 0.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 2.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 2.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 11.3 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 1.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 5.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 2.6 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 1.5 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 5.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 3.0 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 3.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.8 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 1.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 1.7 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 2.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 18.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 1.5 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 1.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 1.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 1.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 1.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 7.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 2.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.2 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 0.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 5.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 17.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 1.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 5.3 | GO:0005814 | centriole(GO:0005814) |
0.0 | 3.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.7 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 7.4 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.0 | 3.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.5 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 0.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 2.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 2.4 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 6.2 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 1.0 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 4.0 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.2 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 29.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.1 | GO:0000138 | Golgi cis cisterna(GO:0000137) Golgi trans cisterna(GO:0000138) |
0.0 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 21.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 1.7 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 1.3 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 4.0 | GO:0030424 | axon(GO:0030424) |
0.0 | 1.2 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.5 | 46.6 | GO:0005186 | pheromone activity(GO:0005186) |
4.2 | 12.5 | GO:0004024 | NADPH:quinone reductase activity(GO:0003960) alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
3.0 | 8.9 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
3.0 | 11.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
2.8 | 8.4 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
2.3 | 48.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
2.0 | 24.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
2.0 | 9.8 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
1.9 | 7.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
1.7 | 5.1 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
1.7 | 5.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.5 | 6.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.5 | 2.9 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
1.4 | 4.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.3 | 3.9 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
1.2 | 3.7 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
1.1 | 3.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.0 | 3.1 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) D5 dopamine receptor binding(GO:0031752) |
1.0 | 24.6 | GO:0005550 | pheromone binding(GO:0005550) |
1.0 | 2.9 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.9 | 5.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.8 | 2.4 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.8 | 3.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.7 | 2.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.7 | 3.6 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.7 | 2.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.7 | 2.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.6 | 3.1 | GO:0070404 | NADH binding(GO:0070404) |
0.6 | 3.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.6 | 1.7 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
0.5 | 3.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.5 | 6.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.5 | 2.0 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.5 | 1.5 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.5 | 1.5 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.5 | 1.9 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.5 | 2.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.5 | 2.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.5 | 1.8 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.4 | 2.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 1.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 1.2 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.4 | 1.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.4 | 3.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 1.9 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 2.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.4 | 2.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 1.1 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.4 | 3.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 3.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.4 | 1.8 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 4.1 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 7.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 4.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 3.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 2.9 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 20.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.3 | 2.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 1.2 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.3 | 8.7 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 1.2 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.3 | 1.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 1.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.3 | 5.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 1.7 | GO:0004103 | choline kinase activity(GO:0004103) |
0.3 | 1.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.3 | 1.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 1.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 3.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 7.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 5.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.7 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 3.7 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 2.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 0.6 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.2 | 4.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 6.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.6 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.2 | 0.7 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.2 | 1.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 1.9 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 0.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.9 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 0.8 | GO:0046980 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
0.1 | 1.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 1.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.7 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.1 | 0.4 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 3.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 1.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 2.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 2.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 1.3 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.1 | 2.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 1.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.3 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 1.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.7 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 1.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 1.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 4.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 2.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 1.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 1.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 1.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 1.5 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 1.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 4.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 2.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 3.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 1.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 4.5 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 0.5 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.1 | 0.9 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.1 | 7.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 1.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 1.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 6.8 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 7.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.4 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.1 | 3.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 3.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 2.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 1.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 1.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 1.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 2.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 1.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 2.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.6 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 3.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 1.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 1.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 2.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 1.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.6 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.0 | 1.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 7.3 | GO:0015293 | symporter activity(GO:0015293) |
0.0 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.2 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 1.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 1.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 1.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 2.5 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 1.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 3.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.7 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 2.9 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 1.1 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 1.3 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 0.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.0 | 1.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.9 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.5 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.5 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 4.6 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.3 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 2.2 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.0 | GO:0004802 | transketolase activity(GO:0004802) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 8.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 4.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 4.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 5.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 2.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 2.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 3.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 2.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 1.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 1.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 4.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 1.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 1.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.5 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 1.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 44.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
2.1 | 12.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.9 | 25.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.6 | 4.3 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.6 | 7.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.5 | 6.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.5 | 7.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 6.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.5 | 3.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 5.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 5.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 10.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 4.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 5.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.3 | 6.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 2.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 2.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 4.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 4.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 2.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 3.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 2.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 13.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 5.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 3.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 6.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 1.9 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 3.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 2.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 2.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 2.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 1.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 4.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 3.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.9 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 2.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 10.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 3.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 3.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 1.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 6.9 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 2.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.6 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 1.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 1.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 1.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 2.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 1.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 2.0 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.8 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 1.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |